Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2014 May;28(5):1155-8.
doi: 10.1038/leu.2013.383. Epub 2013 Dec 24.

ALDH1 activity identifies tumor-initiating cells and links to chromosomal instability signatures in multiple myeloma

Affiliations

ALDH1 activity identifies tumor-initiating cells and links to chromosomal instability signatures in multiple myeloma

W Zhou et al. Leukemia. 2014 May.
No abstract available

PubMed Disclaimer

Figures

Figure 1
Figure 1. A small set of ALDH1+ population induces clonogenic ability and tumor formation in myeloma cells
(A) Representative FACS analysis of the ALDH1+ population in HMCL, ARP1, showed the MM cells without DEAB treatment shifted to the right were considered as ALDH1+ cells (right panel) analyzed by the Aldefluor assay. (B) The percentage of ALDH1+ cells in HMCLs exhibits ~48.5-fold differences, ranging from ~0.1% in case of OPM2 to ~4.85% in case of KMS12BM. Mouse myeloma cells, 5TGM1, fall in the top range of human cell lines. (C) The FACS analysis of ALDH1+ and ALDH1+/ κ+ population shows an existence of low percentage double positive MM cells in primary sample. (D) ALDH+ cells (left) are more clonogenic than ALDH- cells (right). Shown are photographic images of ARP1 and KMS12BM cells forming colonies on soft agar. Colonies were enumerated using a light microscope and means and standard deviations of the mean are indicated at bottom right. The difference in mean colony number of ALDH+ and ALDH cells was statistically significant (p < 0.05) using Student's t test. Morphologic pictures were taken under microscope and number of colonies of ALDH+ and ALDH cells from ARP1 and KMS12BM cells (p < 0.05). Tumorigenicity was evaluated in a xenograft model, mice were injected with ALDH1+ and ALDH1 cells from ARP1 and KMS12BM cells, (E) and tumors dissected from (F) were shown.
Figure 2
Figure 2. Identification of ALDH1 related signatures
(A) A heat map showed 20 genes differentially expressed between ALDH1+ and ALDH1 MM cell lines. (B) A supervised cluster exhibited 20 ALDH1+ associated genes in plasma cells from 22 healthy subjects (NPC), 44 subjects with MGUS, 351 patients with newly diagnosed MM and 9 human MM cell lines (MMCL). Samples within myeloma AAS were ordered so that the predicted AASS increases continuously from left to right. (C) ~ (F) Kaplan-Meier analyses revealed MM patients with a high-AASS had inferior event-free and overall survivals in newly diagnosed TT2 and TT3 cohorts. (G) A scatter-plot showed a positive correlation between the 70-gene risk score (Y-axis) with the ALDH1-associated signature score (AASS) (X-axis). (H) A box-plot showed increases of AASS (Y-axis) in aggressive myeloma genetic subgroups (X-axis) of proliferation (PR) and MAF/MAFB (MF).

References

    1. Ginestier C, Hur MH, Charafe–Jauffret E, Monville F, Dutcher J, Brown M, et al. ALDH1 is a marker of normal and malignant human mammary stem cells and a predictor of poor clinical outcome. Cell stem cell. 2007 Nov;1(5):555–567. - PMC - PubMed
    1. Levi BP, Yilmaz OH, Duester G, Morrison SJ. Aldehyde dehydrogenase 1a1 is dispensable for stem cell function in the mouse hematopoietic and nervous systems. Blood. 2009 Feb 19;113(8):1670–1680. - PMC - PubMed
    1. Matsui W, Wang Q, Barber JP, Brennan S, Smith BD, Borrello I, et al. Clonogenic multiple myeloma progenitors, stem cell properties, and drug resistance. Cancer research. 2008 Jan 1;68(1):190–197. - PMC - PubMed
    1. Moreb JS. Aldehyde dehydrogenase as a marker for stem cells. Current stem cell research & therapy. 2008 Dec;3(4):237–246. - PubMed
    1. Boucher K, Parquet N, Widen R, Shain K, Baz R, Alsina M, et al. Stemness of B-cell progenitors in multiple myeloma bone marrow. Clinical cancer research : an official journal of the American Association for Cancer Research. 2012 Nov 15;18(22):6155–6168. - PMC - PubMed

Publication types